Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme
暂无分享,去创建一个
Ashim K. Mitra | Varun Khurana | A. Mitra | Ripal Gaudana | Ripal Gaudana | Mitan Gokulgandhi | Deep Kwatra | Mitan R. Gokulgandhi | Deep Kwatra | Varun Khurana
[1] R. Sridhar,et al. Inactivation of lysozyme by sonication under conditions relevant to microencapsulation. , 2000, International journal of pharmaceutics.
[2] Daniel E. Otzen,et al. Protein drug stability: a formulation challenge , 2005, Nature Reviews Drug Discovery.
[3] B. Sarmento,et al. Development and characterization of new insulin containing polysaccharide nanoparticles. , 2006, Colloids and surfaces. B, Biointerfaces.
[4] Steven P Schwendeman,et al. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. , 2002, Critical reviews in therapeutic drug carrier systems.
[5] W. Tiyaboonchai,et al. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. , 2007, International journal of pharmaceutics.
[6] E. Topp,et al. Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. , 2008, Journal of pharmaceutical sciences.
[7] D. Sacco,et al. Interaction of a macromolecular polyanion, dextran sulfate, with human hemoglobin , 1986, FEBS letters.
[8] A. Schaper,et al. Charged nanoparticles as protein delivery systems: a feasibility study using lysozyme as model protein. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[9] H. Benson,et al. Development of a chitosan-based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin. , 2008, Biopolymers.
[10] K. Dill,et al. Charge effects on folded and unfolded proteins. , 1990, Biochemistry.
[11] S. Frokjaer,et al. Preparing and evaluating delivery systems for proteins. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] S. Nie,et al. Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .
[13] E. Allémann,et al. Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues , 2005, AAPS PharmSciTech.
[14] A. Mitra,et al. Encapsulation of Protein-Polysaccharide HIP Complex in Polymeric Nanoparticles , 2011, Journal of drug delivery.
[15] Weien Yuan,et al. Formulating protein therapeutics into particulate forms , 2009, Expert opinion on drug delivery.
[16] H. Itagaki,et al. Hemoglobin denaturation caused by surfactants. , 1995, Biological & pharmaceutical bulletin.
[17] J. R. Amrutkar,et al. Chitosan–Chondroitin Sulfate Based Matrix Tablets for Colon Specific Delivery of Indomethacin , 2009, AAPS PharmSciTech.
[18] R. Hurwitz,et al. Painful purpura: an adverse effect to a thrombolysin. , 1990, Archives of dermatology.
[19] Brian M. Murphy,et al. Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.
[20] Wim E. Hennink,et al. Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles , 2000, Pharmaceutical Research.
[21] B. Sarmento,et al. Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles , 2007, International journal of nanomedicine.
[22] M. Manning,et al. Hydrophobic Ion Pairing: Altering the Solubility Properties of Biomolecules , 1998, Pharmaceutical Research.
[23] Dongmei Cun,et al. Design of high payload PLGA nanoparticles containing melittin/sodium dodecyl sulfate complex by the hydrophobic ion-pairing technique , 2009, Drug development and industrial pharmacy.
[24] S. Pispas,et al. Sustained and extended release with structural and activity recovery of lysozyme from complexes with sodium (sulfamate carboxylate) isoprene/ethylene oxide block copolymer. , 2010, Macromolecular bioscience.
[25] L. Dong,et al. Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing. , 2007, International journal of pharmaceutics.
[26] B. Sunderland,et al. An ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticles. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[27] D. Mcclements. Non-covalent interactions between proteins and polysaccharides. , 2006, Biotechnology advances.
[28] K. Kisich,et al. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. , 2005, American Journal of Respiratory and Critical Care Medicine.
[29] T. Park,et al. Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles. , 2001, Journal of pharmaceutical sciences.
[30] Hong Yuan,et al. Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles. , 2009, Colloids and surfaces. B, Biointerfaces.
[31] E. Leo,et al. Fabrication via a nonaqueous nanoprecipitation method, characterization and in vitro biological behavior of N(6)-cyclopentyladenosine-loaded nanoparticles. , 2009, Journal of pharmaceutical sciences.
[32] C. F. van der Walle,et al. Current approaches to stabilising and analysing proteins during microencapsulation in PLGA. , 2009, Expert opinion on drug delivery.